maier paul v  the wall street transcript paul v maier paul v maier is senior vice president and chief financial officer of ligand pharmaceuticals incorporated he joined ligand in october  as vice president and cfo prior to joining ligand mr maier served as vice president finance at dfs west a division of dfs group lp a private multinational retailer from february  to october  mr maier served as vice president and treasurer of icn pharmaceuticals inc a pharmaceutical and biotechnology research products company mr maier held various positions in finance and administration at spi pharmaceuticals inc a publicly held subsidiary of icn pharmaceuticals group from  to  including vice president finance from february  to february  mr maier received an mba from harvard graduate school of business and a bs from pennsylvania state university related interviewspaul maier  ligand pharmaceuticals inc lgndjune  paul v maier  ligand pharmaceuticals lgndseptember   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu   wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google paul v maier  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in paul v maier former board member at international stem cell corporation view full profile are you paul v maier claim your profile   sign up for equilar atlas and view paul v maiers full profile with equilar atlas you can identify corporate executives in paul v maiers network and community follow changes in paul v maiers employment and moneyinmotion connect with paul v maier through your network of contacts paul v maiers executive work history past to view paul v maiers complete executive work history sign up now age      paul v maiers biography paul v maier became a director in july  and has over  years of experience as a senior executive in biotechnology and pharmaceutical companies from november  through his retirement in june  he served as chief financial officer of sequenom inc a publicly held company serving the discovery clinical research and molecular diagnostics market from february  until november  he served as an independent financial consultant previously mr maier was senior vice president and chief financial officer of ligand pharmaceuticals inc a commercial stage biopharmaceutical company a position he held from  to  from  read more paul v maier became a director in july  and has over  years of experience as a senior executive in biotechnology and pharmaceutical companies from november  through his retirement in june  he served as chief financial officer of sequenom inc a publicly held company serving the discovery clinical research and molecular diagnostics market from february  until november  he served as an independent financial consultant previously mr maier was senior vice president and chief financial officer of ligand pharmaceuticals inc a commercial stage biopharmaceutical company a position he held from  to  from  to  mr maier served as vice president finance of dfs west a division of dfs group lp a private multinational retailer from  to  mr maier was employed by icn pharmaceuticals a pharmaceutical and biotechnology research products company where he held various executive positions in finance and general management in icn as well as spi pharmaceuticals a publicly held subsidiary mr maier currently serves on the board of directors of apricus biosciences mabvax therapeutics ritter pharmaceuticals and biological dynamics mr maier received an mba from harvard business school and a bs from pennsylvania state university we believe mr maiers qualifications to serve on our board include his extensive experience in financial management and his service on other boards which brings valuable knowledge and insights to our board source international stem cell corporation on    sign up for equilar atlas and view paul v maiers full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like paul v maier more specifically youll be able to identify corporate executives in paul v maiers network and community follow changes in paul v maiers employment and moneyinmotion connect with paul v maier through your network of conections view full profile   search for over  executive profiles bio example paul v maier popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla david j oconnor president and ceo the madison square garden company claiborne p deming chairman of the board murphy oil corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   william  mary school of business  paul  maier homeexecutive partnersexecutive partners expertise directoryhealthcare paul  maierbiographypaul v maier has over  years of experience as a senior executive in biotechnology and pharmaceutical companies and nearly  years of experience as a director of multiple life science public and private company boards  in addition to his board positions mr maier also currently serves as an advisor to the life science industry  in june  mr maier retired after serving since november  as chief financial officer of sequenom inc a publically held company serving the discovery clinical research and molecular diagnostics market  from february  until november  mr maier served as an independent financial consultant  previously mr maier was senior vice president and chief financial officer of ligand pharmaceuticals inc a commercial stage biopharmaceutical company a position he held from  to   from  to  mr maier served as vice president finance of dfw west a division of dfs group lp a private multinational retailer  from  to  mr maier was employed by icn pharmaceuticals a pharmaceutical and biotechnology research products company where he held various executive positions in finance and general management in icn as well as spi pharmaceuticals a publically held subsidiary  mr maier currently serves on the board of directors of apricus biosciences international stem cell corporation mabvax therapeutics biological dynamics and ritter pharmaceuticals  mr maier received an mba from harvard business school and a bs from pennsylvania state university ritter pharmaceuticals names paul v maier to its board of directors  business wire ritter pharmaceuticals names paul v maier to its board of directors april    am eastern daylight time los angelesbusiness wireritter pharmaceuticals inc a privately held pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases announces the appointment of paul v maier to the company’s board of directors his addition increases board membership to six directors mr maier will chair the company’s audit committee “paul brings us a wealth of operational and financial management expertise from his more than  years of experience as a senior executive in biotechnology and pharmaceutical companies” said ira ritter chairman of the board of directors of ritter pharmaceuticals “paul’s counsel will prove valuable as we advance rpg through the regulatory process and toward commercialization as the first treatment for lactose intolerance we look forward to calling upon his extensive financial capabilities and corporate governance experience as he assumes the important position as audit committee chair we are fortunate to have such a strong addition to our board” mr maier served for five years as the chief financial officer of life sciences company sequenom inc nasdaq sqnm where he was instrumental in raising more than  million in equity and debt financing and commercializing the company’s molecular diagnostics segment he previously served for  years as the senior vice president and chief financial officer of ligand pharmaceuticals inc nasdaq lgnd where he helped build ligand from a venturestage company to a commercial integrated biopharmaceutical organization prior to joining ligand mr maier spent six years in various management and finance positions at icn pharmaceuticals now valeant pharmaceuticals international inc mr maier currently serves on the boards of directors of international stem cell corporation otcqb isco apricus biosciences nasdaq apri mabvax therapeutics otcqb mbvx and biological dynamics he received an mba from harvard business school and a bs from pennsylvania state university about ritter pharmaceuticals ritter pharmaceuticals inc develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases ritter is advancing human gut health research by exploring the metabolic capacity of gut microbiota and translating the functionality of these microbiome modulators into safe and effective applications ritter’s lead drug candidate rpg has the potential to become the first fdaapproved drug for lactose intolerance a condition that affects more than one billion people worldwide forwardlooking statements this release may contain forwardlooking statements which express the current beliefs and expectations of ritter pharmaceuticals’ management such statements involve a number of known and unknown risks and uncertainties that could cause the company’s future results performance or achievements to differ significantly from the results performance or achievements expressed or implied by such forwardlooking statements any statements contained herein that do not describe historical facts including but not limited to statements regarding mr maier’s expected contributions to ritter’s board of directors are forwardlooking statements that involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forwardlooking statements these forwardlooking statements are made only as of the date hereof and the company undertakes no obligation to update or revise the forwardlooking statements whether as a result of new information future events or otherwise contacts lhajody cain jcainlhaicombruce voss bvosslhaicom  release summary ritter pharmaceuticals appoints paul maier to board of directors contacts lhajody cain jcainlhaicombruce voss bvosslhaicom  search advanced news search advanced news search log in sign up paul maier  ligand pharmaceuticals incorporated  zoominfocom hana biosciences appoints paul v maier to board of directors otcbbtlon english français register sign in hana biosciences appoints paul v maier to board of directors march    et  source talon therapeutics inc south san francisco calif march   prime newswire  hana biosciences nasdaqhnab a biopharmaceutical company focused on strengthening the foundation of cancer care today announced the appointment of paul v maier to its board of directors his career has included senior financial leadership positions at ligand pharmaceuticals dfs west and icn pharmaceuticals we are pleased to welcome paul maier to our board said steven r deitcher md president and ceo of hana biosciences paul brings more than  years of experience as a senior financial executive primarily in the pharmaceutical and biotech industries we look forward to his guidance and leadership particularly as a member of our audit committee hanas oncology pipeline has product candidates in all stages of development and therefore offers a breadth of opportunity i am excited to work with the companys management and board of directors as it advances its compounds and continues to grow stated paul v maier from  mr maier served as senior vice president chief financial officer of ligand pharmaceuticals inc a publiclyheld biopharmaceutical company based in san diego ca prior to joining ligand mr maier served as vice president finance at dfs west a division of dfs group lp a private multinational retailer previously mr maier held various positions in finance and administration at icn pharmaceuticals inc a pharmaceutical and biotechnology research products company and its subsidiary spi pharmaceuticals mr maier is currently an independent financial consultant and serves as a director on the boards of pure bioscience inc and international stem cell corp both publiclyheld companies mr maier received an mba from harvard business school and a bs from pennsylvania state university about hana biosciences inc hana biosciences inc nasdaqhnab is a south san francisco cabased biopharmaceutical company focused on acquiring developing and commercializing innovative products to strengthen the foundation of cancer care the company is committed to creating value by building a best inclass team accelerating the development of lead product candidates expanding its pipeline by being the alliance partner of choice and nurturing a unique company culture additional information on hana biosciences can be found at wwwhanabiosciencescom the hana biosciences inc logo is available at httpwwwprimenewswirecomnewsroomprspkgid this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  these statements are often but not always made through the use of words or phrases such as anticipates expects plans believes intends and similar words or phrases these forwardlooking statements include without limitation statements regarding the timing progress and anticipated results of the clinical development regulatory processes potential clinical trial initiations potential ind and nda filings and commercialization efforts of hanas product candidates including its marqibo product candidate such statements involve risks and uncertainties that could cause hanas actual results to differ materially from the anticipated results and expectations expressed in these forwardlooking statements these statements are based on current expectations forecasts and assumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from these statements among other things there can be no assurances that any of hanas development efforts relating to its other product candidates will be successful that hana will be able to obtain regulatory approval of any of its product candidates and that the results of clinical trials will support hanas claims or beliefs concerning the effectiveness of its product candidates additional risks that may affect such forwardlooking statements include hanas need to raise additional capital to fund its product development programs to completion hanas reliance on thirdparty researchers to develop its product candidates and its lack of experience in developing and commercializing pharmaceutical products additional risks are described in the companys annual report on form q for the quarter ended june   filed with the securities and exchange commission hana assumes no obligation to update these statements except as required by law hana biosciences inc investor  media contacts remy bernarda director investor relations   fax   related articles other press releases by talon therapeutics inc spectrum pharmaceuticals acquires talon therapeutics july    talon therapeutics inc reports first quarter  financial results may    talon therapeutics inc reports fourth quarter and year end  financial results april    talon therapeutics to host a conference call to report  financial results and business update on april   march    talon therapeutics announces review of strategic alternatives january     other news releases in health in the last  days  other news releases in directors and officers in the last  days profile talon therapeutics inc   subscribe via rss  subscribe via atom  javascript san mateo california united states   httpwwwtalontxcom contact data hana biosciences inc investor  media contacts remy bernarda director investor relations   fax   contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files talon therapeutics inc logo logo url  copy the link below formats available original medium small tags biotechnology management changes newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved paul maier book package  christian research institute about cri contact connect app speaking canada feed  items  home broadcast broadcast archives hank unplugged hank hanegraaff letter from hank invitation from hank ask hank archive hank speaks out bible answers video events radio stations magazine christian research journal back issues pmr podcast articles shop books audio cd flipcharts dvd pamphlet audio book download my account donate idonate bigsummersaleheaderhero sciidmini muslimheromini cjrpmrmini paul maier book package the paul maier book package includes the following resources pontius pilate by paul maier softcover  pages more than a skeleton by paul maier softcover  pages a skeleton in god’s closet by paul maier softcover  pages the constantine codex by paul maier softcover  pages sku pk categories books packages   pontius pilate  page author paul maier paperback book audience general fiction topic church history in stock more than a skeleton  pages author paul maier publisher thomas nelson paperback book audience general fiction in stock a skeleton in gods closet author paul maier publisher westbow press in stock the constantine codex format softcover number of pages author paul l maier only  left in stock can be backordered add to cart description additional information product description pontius pilate the startling yet untold story of the ambitious and successful roman politician whose fateful verdict forever changes the course of history — but whose conscience can never rest with the consequences in this unique biblical novel dr paul l maier brings to life the roman governor of judea as he rises from the political intrigues of imperial rome and survives the treacherous plotting of herod antipas behind him stands procula a wife who fires his ambition for political advancement while before him stands a bewildering clash of jewish leaders national extremists and religious zealots more than a skeleton when joshua benyosef an israeli from galilee begins assembling twelve followers attracting crowds and performing miracles the world takes notice could dr melvin merton wellknown leader and author of end times books have been correct about the imminent return of christ it seems everyone is a believer in this “messiah” including weber’s wife shannonespecially when joshua performs the “ultimate sign” by raising his disciple from the dead plagued by skepticism weber may be the only one who can intervene before the very foundations of the christian faith are shattered a skeleton in god’s closet dr jonathan weber harvard professor and biblical scholar is looking forward to his sabbatical year on an archaeological dig in israel but a spectacular find that seems to be an archaeologist’s dreamcometrue becomes a nightmare that could be the death rattle of christianity the constantine codex a shocking discovery throws harvard professor jonathan weber into the international spotlight—and could change the way the world sees the bible while touring greek monasteries he finds a manuscript that includes the lost ending of mark and a th book when the codex is stolen jon races to recover it—before it’s lost forever additional information weight  oz related products the prayer of jesus – prayer journal   add to cart the face that demonstrates the farce of evolution   add to cart the covering youth edition   add to cart the complete bible answer book collector’s edition   read more ask hank askhank    contact cri cri    connect with cri po box  charlotte nc    christian research institute  terms  privacy menu home broadcast broadcast archives hank unplugged hank hanegraaff letter from hank invitation from hank ask hank archive hank speaks out bible answers video events radio stations magazine christian research journal back issues pmr podcast articles shop books audio cd flipcharts dvd pamphlet audio book download my account donate idonate ritter pharmaceuticals adds paul maier to the board of directors email protected twitterlinkedin about our vision our mission our team our values our partners faq terms  conditions privacy policy board news latest board news board news by location… europe usa  canada middle east all the others board news by company type public  listed vc  pe backed privately held trust  fund  reit board news by industry… life sciences  health care financials information technology women on board submit a press release board directory company press releases public  listed global  fortune  private or vc  pe backed unicorns trust  fund newsletter contact log in register select pageabout    our vision our mission     our team     our values     our partners     faq     terms  conditions     privacy policy board news    latest board news     board news by location…        europe         usa  canada         middle east         all the others     board news by company type        public  listed         vc  pe backed         privately held         trust  fund  reit     board news by industry…        life sciences  health care         financials         information technology     women on board     submit a press release board directory    company press releases     public  listed     global      fortune      private or vc  pe backed     unicorns     trust  fund newsletter contact log in register homeboard  usa  can board privately held companies ritter pharmaceuticals adds paul maier to the board of directors ritter pharmaceuticals adds paul maier to the board of directors april   by talentboards team comments are off board  usa  can board privately held companies – usa ca – ritter pharmaceuticals inc a privately held pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases announces the appointment of paul v maier to the company’s board of directors his addition increases board membership to six directors mr maier will chair the company’s audit committee “paul brings us a wealth of operational and financial management expertise from his more than  years of experience as a senior executive in biotechnology and pharmaceutical companies” said ira ritter chairman of the board of directors of ritter pharmaceuticals “paul’s counsel will prove valuable as we advance rpg through the regulatory process and toward commercialization as the first treatment for lactose intolerance we look forward to calling upon his extensive financial capabilities and corporate governance experience as he assumes the important position as audit committee chair we are fortunate to have such a strong addition to our board” mr maier served for five years as the chief financial officer of life sciences company sequenom inc nasdaq sqnm where he was instrumental in raising more than  million in equity and debt financing and commercializing the company’s molecular diagnostics segment he previously served for  years as the senior vice president and chief financial officer of ligand pharmaceuticals inc nasdaq lgnd where he helped build ligand from a venturestage company to a commercial integrated biopharmaceutical organization prior to joining ligand mr maier spent six years in various management and finance positions at icn pharmaceuticals now valeant pharmaceuticals international inc mr maier currently serves on the boards of directors of international stem cell corporation otcqb isco apricus biosciences nasdaq apri mabvax therapeutics otcqb mbvx and biological dynamics he received an mba from harvard business school and a bs from pennsylvania state university about ritter pharmaceuticals ritter pharmaceuticals inc develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases ritter is advancing human gut health research by exploring the metabolic capacity of gut microbiota and translating the functionality of these microbiome modulators into safe and effective applications ritter’s lead drug candidate rpg has the potential to become the first fdaapproved drug for lactose intolerance a condition that affects more than one billion people worldwide  disclaimer  news data and statement included in this release are intended exclusively for information purposes product and brand names used in this release maybe trademarks or registered trade marks of their respective owners talentboards accepts neither liability for the consequences of the reader’s reliance nor responsibility for the adequacy or accuracy of this release no data or statement in this release should be considered a recommendation for the purchase retention or sale of the securities referred to hereinother related postsritter pharmaceuticals adds matt foehr to its board of directorstelik adds six new members to the board of directorscpsm appoints henry ritter charles dargan and jeffrey michel to the board of directorstalentboards teamhere the original post  comments are closed latest boardroom news centerstate banks appoints david salyers to the board of directors july   insight engines announces david hornik and erik swan to board along with raising m series a funding led by august capital july   plexchat announces gordon rubenstein to its board along with raising m seed funding led by raine ventures july   square appoints randy garutti to its board of directors july   temperpack announces robert beckler and cody nystrom to board along with raising m series a financing led by sjf ventures july   random boardsdashlanexl groupaccsys technologiesíslandsbankiizettle    talentboards inc  all rights reserved  geneva  miami  london  boston  paris  shanghai  monaco  home site map about us media kit contact us help register now why register login  the leading web portal for pharmacy resources news education and careers july   news drug delivery systems drugstores fda final approvals front page healthcare news generic drugs hospital industry internet pharmacy it in healthcare medicare  medicaid overthecounter drugs pharm industry trends and policy pharmaceutical development pharmaceutical industry pharmacy careers pharmacist pharmacy technician pharmacy job board job placement help so you want a job as a pharmacist start your career as apharmacy technician resources boards of pharmacy drug database fda resources pharmacy associations pharmacy journals pharmacy newsletters state associations more education certification courses continuing education disease state management international pharmacy schools live online ce pharmacy schools pharmacy technician training business advertising information  media kit consulting contact us pharmacy marketing marketplace drug manufacturers drug wholesalers automation and robotics compounding supplies medication  supply dispensing systems tablet  capsule counters wholesalers  distributors more pharmacy choice  pharmaceutical news  ritter pharmaceuticals names paul v maier to its board of directors  july   pharmacy news article    ritter pharmaceuticals names paul v maier to its board of directors los angelesbusiness wire ritter pharmaceuticals inc a privately held pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases announces the appointment of paul v maier to the companys board of directors his addition increases board membership to six directors mr maier will chair the companys audit committee paul brings us a wealth of operational and financial management expertise from his more than  years of experience as a senior executive in biotechnology and pharmaceutical companies said ira ritter chairman of the board of directors of ritter pharmaceuticals pauls counsel will prove valuable as we advance rpg through the regulatory process and toward commercialization as the first treatment for lactose intolerance we look forward to calling upon his extensive financial capabilities and corporate governance experience as he assumes the important position as audit committee chair we are fortunate to have such a strong addition to our board mr maier served for five years as the chief financial officer of life sciences company sequenom inc nasdaq sqnm where he was instrumental in raising more than  million in equity and debt financing and commercializing the companys molecular diagnostics segment he previously served for  years as the senior vice president and chief financial officer of ligand pharmaceuticals inc nasdaq lgnd where he helped build ligand from a venturestage company to a commercial integrated biopharmaceutical organization prior to joining ligand mr maier spent six years in various management and finance positions at icn pharmaceuticals now valeant pharmaceuticals international inc mr maier currently serves on the boards of directors of international stem cell corporation otcqb isco apricus biosciences nasdaq apri mabvax therapeutics otcqb mbvx and biological dynamics he received an mba from harvard business school and a bs from pennsylvania state university about ritter pharmaceuticals ritter pharmaceuticals inc develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases ritter is advancing human gut health research by exploring the metabolic capacity of gut microbiota and translating the functionality of these microbiome modulators into safe and effective applications ritters lead drug candidate rpg has the potential to become the first fdaapproved drug for lactose intolerance a condition that affects more than one billion people worldwide forwardlooking statements this release may contain forwardlooking statements which express the current beliefs and expectations of ritter pharmaceuticals management such statements involve a number of known and unknown risks and uncertainties that could cause the companys future results performance or achievements to differ significantly from the results performance or achievements expressed or implied by such forwardlooking statements any statements contained herein that do not describe historical facts including but not limited to statements regarding mr maiers expected contributions to ritters board of directors are forwardlooking statements that involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forwardlooking statements these forwardlooking statements are made only as of the date hereof and the company undertakes no obligation to update or revise the forwardlooking statements whether as a result of new information future events or otherwise lhajody cain jcainlhaicombruce voss bvosslhaicom  source ritter pharmaceuticals inc copyright business wire  pharmacy news index   drug delivery systems   drugstores   fda final approvals   front page healthcare news   generic drugs   hospital industry   internet pharmacy   it in healthcare   medicare  medicaid   overthecounter drugs   pharm industry trends and policy   pharmaceutical development   pharmaceutical industry live online ce jul  whats new new treatments for type  diabetes jul  management of schizophrenia  acute agitation jul  on the move a comprehensive review of osteoarthritis gout  rheumatoid arthritis jul  obesity management overview of pharmacotherapy aug  treatment of depression and anxiety in older adults click for entire webinar calendar special announcement free membership enjoy drug search industry newsletters and more nursing jobs are you a nurse looking for a job check out the nursing job source your number one choice for nursing jobs websites » rxcareercentercom • rxschoolcom • clubstaffingcom • nursingjobsourcecom • rncom news drug delivery systems drugstores fda final approvals front page healthcare news generic drugs hospital industry internet pharmacy it in healthcare medicare  medicaid overthecounter drugs pharm industry trends and policy pharmaceutical development pharmaceutical industry careers pharmacist pharmacy technician pharmacy job board jobs placement help so you want a job as a pharmacist start your career as apharmacy technician resources boards of pharmacy drug databases fda resources pharmacy associations pharmacy journals pharmacy newsletters state associations more education certification courses continuing education disease state management international pharmacy schools live online ce pharmacy ce pharmacy schools pharmacy tech training business advertising information consulting contact us pharmacy marketing marketplace drug manufacturers drug wholesalers automation and robotics compounding supplies medication  supply   dispensing systems tablet  capsule counters wholesalers  distributors more most popular pharmacy jobs continuing education fda resources drug information pharmacy news disease states pharm tech training copyright   pharmacy choice  all rights reserved terms and conditions  privacy statement  apri paul v maier insider trades for apricus biosciences inc bulletin investor alert tokyo markets open in us market snapshot currencies commodities expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close apricus biosciences inc nasdaq apri go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus apricus biosciences inc market closed  quotes are delayed by  min jul    pm apri quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual paul v maier mr paul v maier is independent nonexecutive director at ritter pharmaceuticals inc independent director at mabvax therapeutics holdings inc independent director at apricus biosciences inc and independent director at international stem cell corp he is on the board of directors at ritter pharmaceuticals inc mabvax therapeutics holdings inc apricus biosciences inc international stem cell corp and biological dynamics inc mr maier was previously employed as chief financial officer by sequenom inc independent director by talon therapeutics inc independent director by pure bioscience inc chief financial officer  senior vice president by ligand pharmaceuticals inc vice presidentfinance by dfs west treasurer  vice president by icn pharmaceuticals inc and vice presidentfinance by spi pharmaceuticals inc he also served on the board at telik inc he received his undergraduate degree from pennsylvania state university and an mba from harvard business school transactions date shares transaction value copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr kleanthis g xanthopoulos chairman mr richard w pascoe chief executive officer cao secretary  director mr neil c morton chief business officer  senior vice president mr brian t dorsey chief development officer  senior vice president ms mary naggs general counsel  vice president mr rusty ray independent director dr wendell d wierenga independent director mr sandford d smith independent director mr paul v maier independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptrafficking suspected after  people found dead  injured in walmart parking lot pthis is what might be next for oj simpson after parole pweekend roundup companies that may cut dividends  faang stocks and market bubbles  enjoy london on the cheap pwhy you might want to avoid these  dividend stocks pattention shoppers ‘amazon effect’ is creating bargain stocks pas gdp will show us economy on same track pstocks brace for volatility in earnings deluge fed meeting looms adunkirk storms us box office with  million debut aoj simpson made over  while in prison and won’t have to give any of it to the goldman family aactor john heard ‘home alone’ dad dead at  amicrosoft rides huge tax benefit from failing at smartphones to big earnings beat aamazon’s foray into groceries means more mergers of food companies experts say ayogaworks ipo pulled on valuation concerns not market conditions aqualcomm’s issues go beyond apple fight apay tv expected to lose more than a million subscribers in latest quarter aexxon earnings will stock trade higher on expected secondquarter beat aalphabet earnings a  billion hit for google potential youtube results for investors achipotle earnings media coverage of the latest illness scare will put earnings targets at risk anolan’s cinematic vision in ‘dunkirk’ is hollywood’s best defense against netflix age earnings departing ceo immelt’s last chance to bring good things to investors loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates search engine marketing sem  bing ads skip to content sign upsign in   you run your business well help find your customers bing ads can help build your business and drive your success spend  and get  in advertising credit† †offer details get  in search advertising when you spend  in bing ads coupon code class first name last name email your website url business phone required microsoft may contact you to provide updates and special offers about bing ads you can unsubscribe at any time to learn more you can read the privacy statement type the code from the image enter security code   × get  in search advertising when you spend  in bing ads †offer details offer expires december   valid only for new bing ads customers who are first party recipients of the offer email a new bing ads customer is one that has not advertised on bing ads before enter promotional coupon code and spend  applies to threshold and prepaid accounts to receive  in bing ads credits limit one promotion code per new bing ads customer promotional code must be redeemed within thirty  days of bing ads new customer account creation ad campaign costs accrued before receiving a credit as well as costs accrued after all credits are used will be charged to the payment method associated with the bing ads account if customer payment fails the coupon amount will not be applied ads will continue to run and accrue costs after any promotional credit has been used up any portion of the credit not used within ninety  days of credit redemption will expire and cant be carried over even if the bing ads customer switches their payment method offer valid only to residents of the united states in order for the offer to be valid a form of payment must be entered into your account prior to redemption of the promotional code and prior to your account going live to take advantage of the credit this offer may not be combined with any other offer promotional code coupon or discount separated redeemed for cash transferred sold or bartered microsoft in its sole discretion can close your account for any suspected coupon abuse refund of the  is not permitted see bing ads terms and conditions for more details at signup other terms and conditions may apply microsoft reserves the right to cancel change or suspend this offer at any time without notice see how bing ads works customers search customers see your ad customers contact you watch how bing ads works     × how bing ads works help more customers find you see how bing can attract customers your google adwords campaigns cant reach  million searchers on the bing network tap into  of the search marketplace get in front of searchers who spend  percent more than the average internet searcher powerful network powerful benefits reach across devicesconnect with customers looking for your business anytime anywhere on any device go global or localreach people in the bing network everywhere or focus on cities counties and areas within a certain distance from your business easy to importif youre already using another product like google adwords its easy to pull that campaign into bing ads you control your costs  free signupjoin bing ads for free and control your account at every step  only pay for clickspay just when customers click on your ad no click no charge  no minimum feestart advertising with a budget that works best for your business   the advantage we gain in cost per click gives us a great return on investment — more than  percent better than google adwords scott redgate search engine marketing manager — cj pony parts by using bing ads features like image extensions and sitelink extensions this auto parts retailer races to convert customers and beat its competition  read about driving more conversions   we might not get as much of the volume as with google adwords but the volume of the traffic that we get converts really well at a lower cost scott schult executive vice president of marketing — myrtle beach area convention and visitors bureau the myrtle beach area convention and visitors bureau uses bing ads to drive site traffic and tourism at lower cost  read about getting better roi better results for less cost thats as simple as i can make it if i look at the quality of the traffic we get for the dollars we spend on bing ads our roi is fantastic alex littlewood ceo   motoroso motoroso a market network for auto enthusiasts gets better results for less cost and reaches a highvalue audience with bing ads  read about attracting quality traffic   import your adwords campaigns save time by importing your google adwords campaigns into bing ads to get ads live quickly sign in with your microsoft account or create one to get started on bing ads from within the bing ads interface select the import from google adwords option enter your google adwords credentials and select the campaign you want to import preview your ad get found online with search engine marketing make the most of your marketing dollars and drive customers to your business see how bing ads can work for you get started today give us a few details about your business to create a bing ads account and get it up and running   sign up get started with bing ads signing up is always free faq is bing ads right for me is bing ads right for my business all types of businesses find value and success with bing ads whether youre focused on local calls and foot traffic or want to drive traffic to your website from across the country or around the world bing ads has solutions for you i already appear in search results for free why should i pay for advertising your current customers may search for your business by name aiming it easy to find you in search results but customers youve yet to reach are more likely searching for general terms that wouldnt necessarily bring up your business in search results advertising next to relevant bing search results puts your business front and center with interested customers you otherwise might not reach what is the difference between seo and sem which one is right for me search engine optimization seo is adjusting your website to improve your natural ranking in search results you cannot pay to improve your website ranking on bing or yahoo thus we often refer to these results and unpaid or organic search results clicks from seo are free but seo also requires technical expertise and involves some factors over which you have only limited control search engine marketing sem is paid advertising that appears next to or above unpaid or organic search results these paid ads are purchased through bing ads you pay for sem clicks but sem gives you more control over when your website appears on results pages and you decide how much you want to pay and you can measure which ads are working and quickly improve your results you dont have to choose between seo and sem you can do both if my time is limited should i still try bing ads yes call a bing ads specialist at and we’ll set up your first campaign for you for free we’ll give you tips on getting the most out of your ads and set you up for success we’re here to help about bing ads where does my ad appear your ads could appear on the top or to the right of bing yahoo and msn search results and you can choose to target your ads to different geographic regions times or days of the week and even demographics what determines my ad position bing ads is a payperclick ppc advertising system you bid based on how much you are willing to pay per each click on your ad because webpages have a limited number of places to show ads we auction those spaces you are bidding against other advertisers to get your ads into the space you want so if you bid on the keyword shoe you will have to beat the bids of the other advertisers who are also bidding on shoe you determine how much you are willing to bid your ad position is based on several things including how closely your ad and website fit with the terms that are searched relevance how your bid compares to other bids in the bing ads auction how strongly your ad has performed in the past and how often it has been clicked clickthrough rate the stronger you are in these areas the better your chances of winning the top ad position how to use bing ads how can i use bing ads to drive more people to my website here are some tips to get better results review your budget and bid strategy if your ad keeps pausing your budget limit may be set too low competitive bids help your ad stay in a strong position to catch eyes and get more clicks to your website expand your targeting both for location and for devices computer mobile and tablet make sure your ads and website are relevant to the keywords you bid on would someone searching your terms expect to see and ad for your business how can i keep my costs down while your first instinct may be to lower your budget first try lowering your maximum bids yes this could mean fewer customers visit your site but if you increase your quality score and build ads with a strong performance history you may be able to win a good ad position with a lower bid that would lower your costperclick and help stretch your budget how do i know if bing ads is working view a wide range of performance trends in your account to quickly see key stats ad clicks the number of times your ad appeared impressions spend average costperclick clickthrough rate average ad position cost per acquisition and conversions you can also run performance reports to get insights into how well your campaigns are doing can i run more than one ad yes in fact we encourage it only one ad will show at a time but running multiple ads lets you test different approaches to see whats working best with your target customers frequently businesses try out different ads for specific products or pages getting started with bing ads how do i get started sign up for bing ads which keywords should i choose you have a few options to help choose your keywords first youll want to think of the terms one of your customers might use to search for your products and offerings those search terms are a great starting point then you can use tools right in your account to find more keywords within bing ads click campaigns on the top of the page click the keywords tab and then click add keywords this will let you search for new keywords based on one you enter search a website for keywords search your destination urls for keywords how can i write a good ad here are a few tips that can help make your ad stand out keep your ads relevant one way to improve relevance is to use your customers most popular search terms in your ad titles and txt describe what sets your product apart use your customers language use words and writing tone that are likely to attract your typical customer be specific this clearer and more specific your offering the better for example rather than big discount specify and exact percentage such as  percent off give customers a reason to click your ad right now offer a specific call to action such as encouraging customers to request a brochure or consultation download a free ebook subscribe to a newsletter or take advantage of a limitedtime discount sign up with bing ads to get started